Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role.
SPEAKERS
Paul Paratore, PharmD, BCPPS, (he/him/él) is a pediatric clinical pharmacist at Denver Health Medical Center in Denver, CO. Paul completed residency training at Seattle Children’s Hospital and received his Doctor of Pharmacy from Auburn University. His role allows him to provide pediatric pharmacy care across a variety of disciplines, with particular interests in pediatric pharmacokinetics, anticoagulation, and pharmacoequity. Paul also has a passion for resident education and manages his institution’s resident mentorship and research support programs.
Gift Nweke, PharmD, MS, BCPS, DPLA, (she/her) is a system pharmacy manager at Novant Health. She supports formulary management by leveraging pharmacoeconomics, outcomes research and variation analysis. Other areas of leadership include resident and student development programs along with training programs for pharmacists and technicians. Gift earned a Doctor of Pharmacy degree at Texas Southern University and completed a combined postgraduate years 1 and 2, MS residency, and graduate program in health system administration at Baylor St. Luke’s Medical Center and the University of Houston.